Coronavirus disease 2019 (COVID-19) death rate differs depending on sex: in Chinese confirmed cases, while the infection rate among men and women is similar, the death rate among men is 4.7% compared with 2.8% for women1. Italian data are similar as the reported death rate in men is significantly higher than that in women, 16.6% vs. 9.1%, respectively. Moreover, preliminary data from Italian epidemics suggest also a significant sex difference in infection rate, being 52.5% in women and 47.5% in men (Integrated Surveillance on COVID19 epidemic in Italy published by Italian Institute of Health, April 28th 2020, https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_28-aprile_2020.pdf).
So far, the mechanisms underlying the observed gender bias are not disclosed; however, some hypotheses can be put forward on the basis of current knowledge on gender differences in respiratory viral diseases.
The sex different lifestyles, such as smoking addiction that is prevalent in men than in women, is considered one of the potential risk factor for developing pneumonia consequent to COVID-192. In addition, it is known that, in general, innate and immune responses are more intense and stronger in females than in males3. This can provide women with a more effective weapon to fight new and infective pathogens, favouring viral clearance.
However, further factors could be taken into account in order to explain the sex bias in COVID-19 death rates. In particular, the human angiotensin-converting enzyme 2 (ACE2), an essential enzyme of the renin–angiotensin system (RAS), is the functional receptor for the severe acute respiratory syndrome coronavirus (SARS-CoV) as well as for the recently identified SARS-CoV-24,5. It has been shown that ACE2 plays a protective role in chronic pathologies, like hypertension, cardiovascular diseases, and acute respiratory distress syndrome, that are the comorbidities representing the risk of worse prognosis in COVID-19. The protective role of ACE2 has been evidenced by studies in mice models, showing more severe lung failure upon ACE2 down-regulation6.
Intriguingly, infection with SARS-CoV induces ACE2 down-regulation through binding of the viral Spike protein to ACE2, thus reducing ACE2 expression in the lung and igniting acute respiratory failure6. Since COVID-19 and SARS patients share similar acute respiratory distress syndrome and a similar gender bias in disease susceptibility and case fatality rates, it is reasonable to believe that they share similar pathogenic mechanisms7.
Estrogen, the primary female sex hormone, has been observed to play a protective role in SARS not only by activating immune response but also suppressing directly SARS-CoV replication8. To note, estrogen inhibits the activity or expression of different components of the renin–angiotensin system. In particular, estrogen is able to upregulate the expression of ACE29.
Furthermore, the gene encoding ACE2 is located on the X chromosome, in sites commonly escaping the inactivation of one X chromosome in mammalian XX cells (XCI), a mechanism that determine the X chromosome transcriptional silencing and avoids redundant gene expression in female cells. However, the silencing is not complete but about 10% of the genes escape the inactivation; as a consequence XX cells over-express genes located in XCI sites, like ACE210.
Consequently, hormonal and genetic factors could lead to ACE2 over-expression in female sex. These insights could, at least partially, account for the better outcome and the lower death rate in female SARS-CoV-2 patients with respect to males. All in all, further studies appear as mandatory to evaluate: (i) whether women who use hormone replacement therapy (HRT) are better protected from respiratory failure than women who do not use HRT; (ii) whether estrogenic agonists, increasing ACE2 expression levels, could represent promising tools to fight the COVID-19 outbreak. Notwithstanding, the study of the role of XCI escaping genes, and of their regulators, could represent a major challenge to understand the sex-specific pathogenic determinants of COVID-19 disease progression.
References
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China CDC Wkly. 2, 113–122 (2020).
Vardavas, C. I. & Nikitara, K. COVID-19 and smoking: a systematic review of the evidence. Tob. Induc. Dis. 18, 20 (2020).
Ghosh, S. & Klein, R. S. Sex drives dimorphic immune responses to viral infections. J. Immunol. 198, 1782–1790 (2017).
Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 94, e00127-20 (2020).
Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lunginjury. Nat. Med. 11, 875–879 (2005).
Hanff, T. C., Harhay, M. O., Brown, T. S., Cohen, J. B. & Mohareb, A. M. Is there an association between COVID-19 mortality and the renin-angiotensin system—a call for epidemiologic investigations. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa329 (2020).
Cheng, H., Wang, Y. & Wang G. Q. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J. Med. Virol. https://doi.org/10.1002/jmv.25785 (2020).
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K. & Perlman, S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J. Immunol. 198, 4046–4053 (2017).
Bukowska, A. et al. Protective regulation of theACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp. Biol. Med. (Maywood) 242, 1412–1423 (2017).
Tukiainen, T. et al. Landscape of X chromosome inactivation across human tissues. Nature 550, 244–248 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by A. Rufini
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gagliardi, M.C., Tieri, P., Ortona, E. et al. ACE2 expression and sex disparity in COVID-19. Cell Death Discov. 6, 37 (2020). https://doi.org/10.1038/s41420-020-0276-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41420-020-0276-1
This article is cited by
-
Insights into estrogen impact in oral health & microbiome in COVID-19
BMC Microbiology (2024)
-
Sex-specific differences in systemic immune responses in MIS-C children
Scientific Reports (2024)
-
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance
Journal of Inflammation (2023)
-
Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis
BMC Infectious Diseases (2023)
-
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Cell Communication and Signaling (2023)